Theta burst stimulation followed by cognitive exercise promising treatment for depression in youth

Written By :  Dr. Kamal Kant Kohli
Published On 2023-03-27 04:30 GMT   |   Update On 2023-03-27 07:28 GMT
Advertisement

Canada: The use of neurotechnological approaches may be promising for treating depression in youth, says a recent study published in the Journal of Affective Disorders Reports. 

Prabhjot Dhami, 1 King's College Circle, Toronto, Canada, and colleagues explored the neurophysiological and clinical effects of using brain stimulation followed by a cognitive exercise to treat Major Depressive Disorder (MDD) in 26 youth ages 16 - 24 years. The specific form of brain stimulation, known as theta-burst stimulation (TBS), has already been shown to be a fast and effective method for treating depression in adults.

Advertisement

TBS involves administering magnetic pulses, or bursts, to stimulate the brain's prefrontal cortex. This area of the brain involves various aspects of cognition, including reasoning, problem-solving, comprehension, and impulse control. It also happens to be a brain region heavily implicated in MDD. For example, impairments to the prefrontal cortex have been linked to symptoms such as rumination and suicidal ideation.

In this study, researchers targeted the prefrontal cortex with repeated sessions of TBS for four weeks in youth participants. Researchers then observed and monitored changes in brain activity using a multimodal brain mapping technique of transcranial magnetic stimulation combined with electroencephalography (TMS-EEG).

At the end of the four-week trial, researchers noted significant changes in brain activity in the treatment regions and regions that were not directly stimulated with TBS. Changes in brain activity were also associated with a reduction in depressive and rumination scores.

More treatment options needed

"Major Depressive Disorder affects approximately 11 per cent of adolescents and youth, but existing treatments, such as medication and/or psychotherapy, fail to significantly improve symptoms in about 30 - 50 per cent of cases," says Farzan, a professor in SFU's School of Mechatronic Systems Engineering (MSE). She also holds the chair in Technology Innovations for Youth Addiction Recovery and Mental Health and heads SFU's new eBrain Lab.

Researchers note that some medications have also been associated with side effects in youth, such as suicidal thoughts and behaviours – leading to the search for safer treatment options.

Building on previous research

Previous research has shown a link between dysfunction of the prefrontal cortex and MDD. "Using TMS-EEG brain mapping technology, we also found that the prefrontal cortex in youth with MDD exhibited greater brain activity than healthy youth. It was very interesting to see in the current study that four weeks of TBS treatment seemed to reduce this excessive brain activity, possibly reflecting a return to a 'healthy' state," says SFU doctoral student Prabhjot Dhami, the study's first author.

Prefrontal cortex impairments in youth with MDD may also contribute to symptoms such as rumination and suicidal ideation/behaviour, Farzan notes. Since the prefrontal cortex is critical for executive functioning, dysfunction or deficits in this region can lead to the onset and maintenance of depressive symptoms.

The researchers say neurotechnological treatments, such as the combination of TBS targeted to the prefrontal cortex, followed by a cognitive exercise that may also engage this brain area, have the potential to optimize the impact on the prefrontal cortex in youth MDD to alleviate symptoms more effectively.

Reference:

Prabhjot Dhami, Jonathan Lee, Benjamin Schwartzmann, Yuliya Knyahnytska, Sravya Atluri, Gregory J. Christie, Paul E. Croarkin, Daniel M. Blumberger, Zafiris J. Daskalakis, Sylvain Moreno, Faranak Farzan, Neurophysiological impact of theta burst stimulation followed by cognitive exercise in treatment of youth depression, Journal of Affective Disorders Reports, https://doi.org/10.1016/j.jadr.2022.100439.

Tags:    
Article Source : Journal of Affective Disorders

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News